Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  DexCom, Inc.    DXCM

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/22/2017 03/23/2017 03/24/2017 03/27/2017 03/28/2017 Date
76.9(c) 76.08(c) 82.62(c) 83.4(c) 84.01(c) Last
918 571 786 798 1 487 708 753 641 636 109 Volume
+0.54% -1.07% +8.60% +0.94% +0.73% Change
More quotes
Financials ($)
Sales 2017 737 M
EBIT 2017 -40,3 M
Net income 2017 -47,1 M
Finance 2017 127 M
Yield 2017 -
Sales 2018 974 M
EBIT 2018 22,6 M
Net income 2018 15,8 M
Finance 2018 201 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018 711,35
EV / Sales2017 9,50x
EV / Sales2018 7,11x
Capitalization 7 125 M
More Financials
Company
DexCom, Inc. is a medical device manufacturing company.The company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic... 
More about the company
Surperformance© ratings of DexCom, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on DEXCOM, INC.
03/25 INSIDER TRADING ACTIVITY DEXCOM, INC : DXCM) – EVP Sold 3,182 shares of St..
03/25 INSIDER TRADING ACTIVITY DEXCOM, INC : DXCM) – CFO Sold 2,000 shares of St..
03/24 DEXCOM : Glucose monitor maker DexCom jumps on Medicare ruling
03/24 DEXCOM : Medicare Announces Criteria Covering Dexcom G5 Mobile CGM for All Peopl..
03/23 DEXCOM SCHEDULES FIRST QUARTER 2017 : 30 p.m. Eastern Time
03/22 INSIDER TRADING ACTIVITY DEXCOM, INC : DXCM) – CEO Sold 10,000 shares of S..
03/16 DEXCOM, INC. : Post Earnings Coverage as DexCom's Q4 Top-line Surged 31%; Outshi..
03/16 INSIDER TRADING ACTIVITY DEXCOM, INC : DXCM) – SVP Sold 21,317 shares of S..
03/13 DEXCOM, INC. (NASDAQ : DXCM) Files An 8-K Departure of Directors or Certain Offi..
03/13 DEXCOM : Appoints Richard Collins to Board of Directors
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
03/28DJMEDTRONIC : Files 8K - Entry Into Definitive Agreement
03/28DJMEDTRONIC : Files 8K - Entry Into Definitive Agreement
03/22DJMEDTRONIC : Files 8K - Other Events
03/17DJMEDTRONIC : Less-Invasive Treatment Yielded Similar Outcome as Open-Heart Surger..
03/11DJLUXOTTICA : Smart Glasses Get a Fresh Look -- WSJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
03/25Wall Street's Initial Reaction to More Obamacare - Trading with The Fly $IYH ..
1
03/24#Medicare unveils coverage criteria for Dexcom's continuous glucose monitor
4
03/24Medicare clarifies criteria for coverage of DexCom's G5 CGM System; shares ah.. 
03/24DexCom Release: Medicare Announces Criteria Covering Dexcom G5 Mobile CGM For.. 
03/24Cowen says Dexcom CMS decision, broader, sooner than expected:
1
More tweets
Qtime:24
News from SeekingAlpha
03/24 Medicare clarifies criteria for coverage of DexCom's G5 CGM System; shares ah..
03/24 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
03/16 The Fed Acted Rationally - Cramer's Mad Money (3/15/17)
03/01 Lean Long-Term Growth Portfolio - February 2017 Update
03/01 DexCom (DXCM) Q4 2016 Results - Earnings Call Transcript
Advertisement
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | DXCM | US2521311074 | 4-Traders
Full-screen chart
Technical analysis trends DEXCOM, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 89,5 $
Spread / Average Target 6,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Kevin Ronald Sayer President, Chief Executive Officer & Director
Terry H. Gregg Executive Chairman
Jeffrey C. Moy Senior Vice President-Operations
Jess Roper Chief Financial Officer & Senior Vice President
Jorge A. Valdes Chief Technology Officer & Executive VP
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
DEXCOM, INC.40.72%7 125
MEDTRONIC PLC13.76%110 524
BAXTER INTERNATIONAL I..17.03%28 122
ZIMMER BIOMET HOLDINGS..17.43%24 372
HOYA CORPORATION11.01%19 156
C R BARD INC11.49%18 113
More Results